N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

C154H147F9N16O7 — CID 160700398

IUPACN-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
SMILESCCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c(C)c1.Cc1ccccc1-c1cccnc1[C@@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.Cc1ccccc1-c1cccnc1[C@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
InChIInChI=1S/C32H33F3N4O.2C31H28N2O2.2C30H29F3N4O/c1-3-22-15-16-24(21(2)18-22)25-13-9-17-36-30(25)27(19-23-10-5-4-6-11-23)37-29(40)20-39-28-14-8-7-12-26(28)31(38-39)32(33,34)35;2*1-21-8-5-6-11-27(21)28-12-7-15-32-31(28)23(16-22-9-3-2-4-10-22)17-26(35)18-24-20-33-30-14-13-25(34)19-29(24)30;2*1-20-10-5-6-13-22(20)23-15-9-17-34-28(23)25(18-21-11-3-2-4-12-21)35-27(38)19-37-26-16-8-7-14-24(26)29(36-37)30(31,32)33/h4-6,9-11,13,15-18,27H,3,7-8,12,14,19-20H2,1-2H3,(H,37,40);2*2-15,19-20,23,33-34H,16-18H2,1H3;2*2-6,9-13,15,17,25H,7-8,14,16,18-19H2,1H3,(H,35,38)/t27-;2*23-;2*25-/m11010/s1
InChIKeyRQNSMFNCCRTMII-RGZDSKPYSA-N
MW2504.96 g/mol
LogP32.86
Rot. Bonds38

About N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide

N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (PubChem CID 160700398) has the molecular formula C154H147F9N16O7 and a molecular weight of 2504.96 g/mol. Its IUPAC name is N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.

Molecular Properties

Compound NameN-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
PubChem CID160700398
Molecular FormulaC154H147F9N16O7
Molecular Weight2504.96 g/mol
Exact Mass2503.15
IUPAC NameN-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
SMILESCCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c(C)c1.Cc1ccccc1-c1cccnc1[C@@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.Cc1ccccc1-c1cccnc1[C@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2
InChIInChI=1S/C32H33F3N4O.2C31H28N2O2.2C30H29F3N4O/c1-3-22-15-16-24(21(2)18-22)25-13-9-17-36-30(25)27(19-23-10-5-4-6-11-23)37-29(40)20-39-28-14-8-7-12-26(28)31(38-39)32(33,34)35;2*1-21-8-5-6-11-27(21)28-12-7-15-32-31(28)23(16-22-9-3-2-4-10-22)17-26(35)18-24-20-33-30-14-13-25(34)19-29(24)30;2*1-20-10-5-6-13-22(20)23-15-9-17-34-28(23)25(18-21-11-3-2-4-12-21)35-27(38)19-37-26-16-8-7-14-24(26)29(36-37)30(31,32)33/h4-6,9-11,13,15-18,27H,3,7-8,12,14,19-20H2,1-2H3,(H,37,40);2*2-15,19-20,23,33-34H,16-18H2,1H3;2*2-6,9-13,15,17,25H,7-8,14,16,18-19H2,1H3,(H,35,38)/t27-;2*23-;2*25-/m11010/s1
InChIKeyRQNSMFNCCRTMII-RGZDSKPYSA-N
XLogP32.86
TPSA311.39 Ų
H-Bond Donors7
H-Bond Acceptors18
Rotatable Bonds38
Heavy Atoms186
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002504.96
LogP ≤ 532.86
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1018

Analyze N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The IUPAC name of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (CID 160700398) is N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.
What is the SMILES notation for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The canonical SMILES for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is CCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)c(C)c1.Cc1ccccc1-c1cccnc1[C@@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.Cc1ccccc1-c1cccnc1[C@H](CC(=O)Cc1c[nH]c2ccc(O)cc12)Cc1ccccc1.Cc1ccccc1-c1cccnc1[C@H](Cc1ccccc1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2.
What is the InChIKey of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
The InChIKey is RQNSMFNCCRTMII-RGZDSKPYSA-N. The full InChI is InChI=1S/C32H33F3N4O.2C31H28N2O2.2C30H29F3N4O/c1-3-22-15-16-24(21(2)18-22)25-13-9-17-36-30(25)27(19-23-10-5-4-6-11-23)37-29(40)20-39-28-14-8-7-12-26(28)31(38-39)32(33,34)35;2*1-21-8-5-6-11-27(21)28-12-7-15-32-31(28)23(16-22-9-3-2-4-10-22)17-26(35)18-24-20-33-30-14-13-25(34)19-29(24)30;2*1-20-10-5-6-13-22(20)23-15-9-17-34-28(23)25(18-21-11-3-2-4-12-21)35-27(38)19-37-26-16-8-7-14-24(26)29(36-37)30(31,32)33/h4-6,9-11,13,15-18,27H,3,7-8,12,14,19-20H2,1-2H3,(H,37,40);2*2-15,19-20,23,33-34H,16-18H2,1H3;2*2-6,9-13,15,17,25H,7-8,14,16,18-19H2,1H3,(H,35,38)/t27-;2*23-;2*25-/m11010/s1.
What are the key properties of N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide?
N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide has a molecular weight of 2504.96 g/mol, XLogP of 32.86, 38 rotatable bonds, 7 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-[3-(4-ethyl-2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;(4R)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;(4S)-1-(5-hydroxy-1H-indol-3-yl)-4-[3-(2-methylphenyl)-2-pyridinyl]-5-phenylpentan-2-one;N-[(1S)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(2-methylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide is sourced from PubChem (CID 160700398), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).